Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Capital Expenditures (2021 - 2025)

Lucid Diagnostics' Capital Expenditures history spans 5 years, with the latest figure at $51000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 80.31% year-over-year to $51000.0; the TTM value through Dec 2025 reached $197000.0, down 33.45%, while the annual FY2025 figure was $197000.0, 33.45% down from the prior year.
  • Capital Expenditures reached $51000.0 in Q4 2025 per LUCD's latest filing, up from $28000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.8 million in Q3 2022 to a low of $1000.0 in Q2 2021.
  • Average Capital Expenditures over 5 years is $280941.2, with a median of $37000.0 recorded in 2024.
  • Peak YoY movement for Capital Expenditures: soared 23500.0% in 2022, then tumbled 99.5% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $824000.0 in 2021, then soared by 241.75% to $2.8 million in 2022, then tumbled by 93.79% to $175000.0 in 2023, then skyrocketed by 48.0% to $259000.0 in 2024, then crashed by 80.31% to $51000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Capital Expenditures are $51000.0 (Q4 2025), $28000.0 (Q3 2025), and $25000.0 (Q2 2025).